|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 133.21 USD | +1.80% |
|
+2.30% | +8.53% |
| 08-05 | Gilead Sciences Delivers 'Plenty' to Like in Q2, RBC Says | MT |
| 08-05 | Leerink Partners Adjusts Price Target on Gilead Sciences to $130 From $126 | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +1.80% | +2.30% | -2.31% | -0.63% | +8.53% | +20.79% | +65.13% | +93.68% | +65.66% | 165B | |
| -0.52% | +3.21% | -4.03% | +21.62% | +10.33% | +85.02% | +161.12% | +350.09% | +1,353.79% | 1,057B | |
| +0.88% | +1.13% | -2.99% | +16.51% | +25.27% | +51.13% | +49.76% | +49.75% | +108.66% | 625B | |
| +0.89% | -1.95% | -3.38% | +21.38% | +7.68% | +23.73% | +63.67% | +114.98% | +269.76% | 435B | |
| +0.71% | +3.87% | +8.19% | +15.39% | +11.91% | +47.45% | +38.68% | +3.98% | +46.74% | 363B | |
| +0.64% | -0.49% | -0.65% | +11.19% | +14.95% | +35.39% | +40.21% | +50.87% | +54.48% | 296B | |
| +0.39% | -5.83% | -17.18% | -10.65% | -13.73% | +8.64% | +9.28% | +45.84% | +127.89% | 249B | |
| +1.51% | +6.69% | +11.64% | +24.87% | +25.55% | +44.34% | +62.47% | +78.56% | +136.64% | 222B | |
| +3.92% | -0.46% | -6.83% | +3.25% | -6.20% | -1.21% | -44.09% | -2.66% | +84.91% | 209B | |
| +2.14% | +7.00% | +11.18% | +1.06% | +7.47% | +10.44% | -25.00% | -40.63% | -24.49% | 153B | |
| +0.89% | -0.90% | +11.64% | +15.06% | +19.99% | +42.68% | +7.03% | -4.99% | +2.28% | 132B | |
| +2.49% | +3.98% | -5.01% | +16.72% | +9.42% | +32.06% | +43.66% | +147.21% | +384.30% | 126B | |
| +1.24% | +1.50% | -2.12% | +5.49% | +7.45% | +41.76% | +44.99% | +9.19% | -7.44% | 106B | |
| +1.35% | +1.13% | -0.62% | +2.13% | -8.96% | -6.84% | -20.11% | -12.68% | +3.83% | 104B | |
| +1.37% | -1.08% | -10.01% | -15.29% | -16.81% | -7.34% | +64.16% | +71.38% | +480.28% | 71.54B | |
| +0.83% | +3.66% | -1.99% | +33.08% | +34.59% | +96.33% | -4.89% | +5.93% | -48.04% | 56.57B | |
| +2.12% | +0.49% | +1.69% | +4.33% | +14.58% | +30.97% | +26.69% | +52.70% | +19.68% | 56.09B | |
| +4.82% | +1.00% | -1.34% | +1.75% | -8.31% | -10.18% | +39.59% | -0.33% | +235.78% | 53.41B | |
| -0.32% | +1.68% | +1.09% | +10.24% | -1.44% | +4.65% | +14.40% | - | - | 43.91B | |
| +1.58% | +1.00% | +2.05% | -1.81% | +13.30% | +117.07% | +267.19% | +253.25% | -34.77% | 41.2B | |
| Average | +1.44% | +1.37% | -0.55% | +8.78% | +7.78% | +33.34% | +45.20% | +66.64% | +171.58% | 228.22B | |
| Weighted average by Cap. | +0.87% | +1.38% | -1.46% | +13.44% | +10.43% | +44.07% | +65.20% | +119.79% | +404.45% |
- Stock Market
- Stocks
- GILD Stock
- Sector Gilead Sciences, Inc.
Select your edition
All financial news and data tailored to specific country editions
